HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Lords Mark Industries completes Phase I of expansion plan at Silvassa facility
Sep-16-2026

Lords Mark Industries has successfully completed Phase I of its expansion plan at its Silvassa facility, nearly three months ahead of its originally committed December 2026 timeline. The surgical and orthopaedic product portfolio has expanded significantly from 36 to 54 SKUs, with the addition of 18 new products. The newly expanded production line is scheduled to commence commercial operations from October 11, 2026.  

The company's existing portfolio of 36 surgical and orthopaedic products already holds US FDA approval. The newly introduced 18 SKUs are currently progressing through the US FDA approval process and are anticipated to receive clearance before December 2026.

This strategic expansion reinforces the company's manufacturing capabilities, broadens its market reach across domestic and international healthcare ecosystems, and supports its long-term vision of becoming a recognized global player in the medical devices industry. 

Lords Mark Industries is engaged in consultancy in various fields including trading in capital market instruments; market research and follow-up across multiple industries; turnkey power projects consultancy; and undertaking energy and infrastructure projects.


  RELATED NEWS >>